Baseline circulating tumor DNA (ctDNA) biomarker analysis of patients with human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic non-small cell lung cancer (NSCLC) treated with trastuzumab deruxtecan (T-DXd) Meeting Abstract
| Authors: | Smit, E. F.; Felip, E.; Uprety, D.; Nagasaka, M.; Nakagawa, K.; Paz-Ares, L.; Pacheco, J.; Li, B. T.; Planchard, D.; Baik, C. S.; Goto, Y.; Murakami, H.; Pereira, K. M. C.; Taguchi, A.; Kogo, M.; Kuwahara, Y.; Zou, M.; Feng, W.; Tsuchihashi, Z.; Jänne, P. A. |
| Abstract Title: | Baseline circulating tumor DNA (ctDNA) biomarker analysis of patients with human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic non-small cell lung cancer (NSCLC) treated with trastuzumab deruxtecan (T-DXd) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S241 |
| End Page: | S242 |
| Language: | English |
| ACCESSION: | WOS:001087480200147 |
| DOI: | 10.1016/j.annonc.2023.09.2875 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 151P -- Source: Wos |
